Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
What do teens and tweens want for the holidays? E-bikes, gift cards and lip tints. - 2Brazil expands pesticide packaging reverse logistics
- 3What to know as New York City nurses strike for a 3rd day
- 410 High priority Contraptions for Tech Aficionados
- 5FDA updates risk classification for voluntary shredded cheese recall
- Pick Your #1 game to observe
- Exploring the School Application Cycle: Understudy Bits of knowledge
- NASA counts down for first crewed lunar mission in half a century
- Inside The Design-Forward Wellness Hotel Marking A New Chapter In Medellín
- I asked ChatGPT who would win a Golden Globes. Here's what it got right — and totally wrong.
- Africa's energy giants eye long-term gains on Iran war disruption
- Iran denies launching ballistic missiles towards Kurdistan region of Iraq
- James Webb Space Telescope's mysterious 'little red dots' may be black holes in disguise
- U.S. to drop childhood vaccine recommendations as it looks to Denmark, Washington Post reports
